Virtual 5th Annual Chronic Traumatic Encephalopathy Conference - October 21 and 22, 2021
Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease of the brain found in athletes (and others) with a history of repetitive brain trauma, including symptomatic concussions as well as asymptomatic subconcussive hits to the head. Brain degeneration is associated with memory loss, confusion, impaired judgment, impulse control problems, aggression, depression, and, eventually, progressive dementia.
During this virtual two-day course participants will learn about all aspects of CTE including its pathology, pathophysiology, genetics, biomarkers, imaging, clinical syndromes, clinical criteria, differential diagnosis, impact on veterans and implications for the family, and what it is like to live with or worry about the disease.
This Conference is for Intermediate and Advanced clinicians.
Poster Session - Call for Abstracts
The BU Alzheimer’s Disease Research Center is now accepting abstracts for the 2021 CTE Conference poster session. The call for posters is open to students of all levels, trainees, researchers, and faculty who are involved in research related to Alzheimer’s disease, dementia, aging, and related topics. Poster abstracts are due Tuesday, September 7, and must be submitted online. Accepted poster presenters will be notified by Tuesday, September 14.
- Dementia Specialists
- Graduate & Postdoctoral Students
- Nurses & Nurse Practitioners
- Physical Therapists
- Physicians & Physicians Assistants
- PTSD Specialists
- Rehabilitative Services
- Sport Psychology Consultants
Through lectures, question and answer sessions, and panel discussions participants at the conclusion of this conference will be able to:
- Identify the pathology of CTE
- Describe the clinical syndrome of CTE
- Identify bio markers of CTE
- Describe the co-morbidity of Alzheimer’s Disease & related disorders
- Identify the risk factors of CTE
- Identify different types of exposures for CTE
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
Michael Alosco, Ph.D.
Assistant Professor of Neurology, Boston University School of Medicine
Kaj Blennow, MD
Professor/ Chief Physician
Department of Psychiatry and Neurochemistry, University of Gothenburg
Andrew Budson, MD (Course Co-Director)
Chief of Cognitive & Behavioral Neurology, Associate Chief of Staff for Education, and Director of the Center for Translational Cognitive Neuroscience at the Veterans Affairs (VA) Boston Healthcare System, Associate Director for Research at the Boston University Alzheimer’s Disease Center, Professor of Neurology at Boston University School of Medicine, Leader of Outreach, Recruitment and Education Core, and Lecturer in Neurology at Harvard Medical School.
Robert Cantu, MD, FACS
Medical Director and Director of Clinical Research at the Cantu Concussion Center at Emerson Hospital, Concord, MA.
Lee Goldstein, MD, Ph.D.
Associate Professor, Biomedical Engineering, Associate Professor, Psychiatry, Neurology, Opthalmology, Pathology and Laboratory Medicine, Director, Molecular Aging and Development Laboratory, Director, Translation Core, NIH Alzheimer’s Disease Center, Director, Center for Biometals & Metallomics (CBM), Director, Molecular Biophotonics Laboratory (MBL)
Jasmeet Hayes, PhD
Associate Professor, Clinical Area, Department of Psychology, Boston University
Douglas Katz, MD
Professor of Neurology, Boston University School of Medicine
Ann Mckee, MD
Professor of Neurology & Pathology , Director, Neuropathology Core
William Fairfield Warren Distinguished Professor of Neurology and Pathology at Boston University, Director of Neuropathology for VA Boston, and Director of the BU Chronic Traumatic Encephalopathy (CTE) Center.
Jesse Mez, M.D., M.S.
Associate Professor of Neurology, Boston University School of Medicine
Alzheimer’s Disease Center Clinical Core Associate Director
Chris Nowinski, PhD
Co-Founder, CEO, Concussion Legacy Foundation
Thor Stein, MD, Ph.D.
Associate Professor of Pathology and Laboratory Medicine
Associate Director of the Neuropathology Core of the Boston University Alzheimer Disease Center
Assistant Professor, Neurology
Program Manager – Samrana Bertrand
CME Program Manager - Naomi Moeller
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 13.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This program is sponsored by the Massachusetts Psychological Association. Massachusetts Psychological Association is approved by the American Psychological Association to sponsor continuing education for psychologists. Massachusetts Psychological Association maintains responsibility for this program and its content.
- 13.50 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 13.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 13.50 Participation
Clinicians - $325
Students/Resident Assistants - Free
BUSM CME complies with the ADA and the rules and regulations thereof to make reasonable accommodations for our educational activities. If any participant in this educational activity is in need of accommodations, please contact BUSM CME at email@example.com.
Substitutions may be made at any time without an additional charge. Refunds, less an administrative fee of $75, will be issued for all cancellations received two weeks prior to the start of the conference. Should cancellation occur within the two-week window, a credit will be issued, not a refund. Credits will be honored for up to two years. “No shows” are subject to the full course fee. Cancellations/substitution(s) must be made in writing. Refunds or credits will not be issued once the conference has started. This course is subject to change or cancellation.